Vitamins E and C Fail to Beat Placebo in Preventing
Cardiovascular Disease in Older Men
Earlier studies have suggested E helps fight
cardiovascular disease, C reduces risk of heart disease
Nov. 10, 2008 - Neither vitamin E nor vitamin C
supplements reduced the risk of major cardiovascular events in a large,
long-term study of older male physicians, according to a study in the
November 12 issue of the Journal of the American Medical Association (JAMA). The article was released early online
yesterday to coincide with the scientific presentation of the study
findings at the American Heart Association meeting.
March 3, 2006 Vitamin E good or bad has been
a hot topic in medicine for the last couple of years. New research at
Ohio State University, looking at how two forms of vitamin E act inside
animal cells, has concluded this powerful antioxidant, popular with
senior citizens, is "truly a
double-edged sword."
Read more...
A majority of adults in the United States are
reported to have taken vitamin supplements in the past year, according
to background information provided by the authors.
"Basic research studies suggest that vitamin E,
vitamin C, and other antioxidants reduce cardiovascular disease by
trapping organic free radicals, by deactivating excited oxygen
molecules, or both, to prevent tissue damage," according to the report.
Some previous observational studies have supported
a role for vitamin E in cardiovascular disease prevention. Some previous
observational studies have also shown a role for vitamin C in reducing
coronary heart disease risk. These earlier studies had opened the door
on a rush by Americans senior citizens, in particular to taking
these supplements to protect them from heart problems.
In this study, known as the Physicians' Health
Study II, Howard D. Sesso, Sc.D, M.P.H., and colleagues from Brigham and
Women's Hospital, Harvard Medical School and School of Public Health and
VA Boston Healthcare System, Boston, assessed the effects of vitamin E
and vitamin C supplements on the risk of major cardiovascular disease
events among 14,641 male physicians.
Eating a diet rich in vitamins E and C was found
to lower risk of cancer in earlier studies
Nov. 17, 2008 It has not been a good month for
vitamins E and C. A study released yesterday found no protective effect
from vitamin E on prostate cancer or vitamin C supplementation on total
cancer. This follows a study released earlier in the month that says
neither vitamin E nor vitamin C
supplements reduced the risk of major cardiovascular events in a study
of older men. Read more...
These physicians were 50 years or older and at low
risk of cardiovascular disease at the beginning of the study in 1997,
and 754 (5.1 percent) had prevalent cardiovascular disease. The study
participants were randomized to receive 400 IU of vitamin E every other
day or a placebo and 500 mg of vitamin C daily or a placebo.
"During a mean (average) follow-up of 8 years,
there were 1,245 confirmed major cardiovascular events," the researchers
report.
There were 511 total myocardial infarctions (heart
attacks), 464 total strokes, and 509 cardiovascular deaths, with some
men experiencing multiple events.
A total of 1,661 men died during follow-up.
Compared with placebo, neither vitamin E nor
vitamin C had an effect on the prevention of major cardiovascular
events.
"Neither vitamin E nor vitamin C had a significant
effect on total mortality, but vitamin E was associated with an
increased risk of hemorrhagic stroke."
In conclusion the authors write: "In this large,
long-term trial of male physicians, neither vitamin E nor vitamin C
supplementation reduced the risk of major cardiovascular events. These
data provide no support for the use of these supplements for the
prevention of cardiovascular disease in middle-aged and older men."
Editor's Note: This work was supported by grants
from the National Institutes of Health and an investigator-initiated
grant from BASF Corporation. Study agents and packaging were provided by
BASF Corporation, Wyeth Pharmaceuticals, and DSM Nutritional Products
Inc. (formerly Roche Vitamins). Please see the article for additional
information, including other authors, author contributions and
affiliations, financial disclosures, funding and support, etc.
Keep up with the latest news for senior citizens, baby
boomers